Soley Therapeutics: Funding, Investors & Team (Sep 2026)
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs, using image acquisition-based approaches. Soley Therapeutics has taken an orthogonal approach to discover new drugs by developing a technology platform to measure how cells respond multi-dimensionally in response to drugs. We have developed a novel platform for high-content phenotypic drug screening, where the drug effect on a cell can be visualized via molecular-microscopic images and analyzed by using sophisticated AI tools.
Soley Therapeutics has raised $200M across 1 funding round on record, the most recent a Series C of $200M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Soley Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Soley Therapeutics Funding Rounds
Soley Therapeutics Founders and Leadership Team
Contact details for the Soley Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Soley Therapeutics Funding Compared to Other Biotechnology Startups
Soley Therapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Soley Therapeutics in Biotechnology and San Francisco
Companies Similar to Soley Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Soley Therapeutics Funding FAQs
What does Soley Therapeutics do?
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs, using image acquisition-based approaches. Soley Therapeutics has taken an orthogonal approach to discover new drugs by developing a technology platform to measure how cells respond multi-dimensionally in response to drugs. We have developed a novel platform for high-content phenotypic drug screening, where the drug effect on a cell can be visualized via molecular-microscopic images and analyzed by using sophisticated AI tools.
How much funding has Soley Therapeutics raised?
Soley Therapeutics has raised $200M across 1 round on record. The most recent is a Series C of $200M announced in Jan 2026.
When did Soley Therapeutics last raise funding?
Soley Therapeutics' most recent funding round on record is a Series C of $200M, announced in Jan 2026.
Who founded Soley Therapeutics?
FundedIQ lists Yerem Yeghiazarians (Founder) at Soley Therapeutics.
Where is Soley Therapeutics headquartered?
Soley Therapeutics is based in San Francisco, California, United States.
How many employees does Soley Therapeutics have?
Soley Therapeutics is in the 11-50 employee band.
How does Soley Therapeutics' funding compare to other Biotechnology startups?
Soley Therapeutics' latest round of $200M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Soley Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Soley Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.